GlassScriptPhysician profile
Jose Dominguez
NPI 1295773927
$421.89
in general payments reported to CMS, 2019-2025
9 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.30 · 2021: $18.71 · 2022: $59.23 · 2023: $150 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $152.06 | 2021-2023 | Gi Genius |
| Intuitive Surgical, INC. | $59.23 | 2022 | |
| Tela Bio, INC. | $50.00 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vertex Pharmaceuticals Incorporated | $42.92 | 2025 | |
| Baxter Healthcare | $33.09 | 2025 | Seprafilm |
| Innovation Technologies INC | $31.00 | 2019 | |
| Boston Scientific Corporation | $24.44 | 2025 | Axonics |
| Axonics, INC. | $16.85 | 2023 | Axonics |
| Merck Sharp & Dohme LLC | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Dominguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.